Best Clinical Paper 2023
“ Toker Cell Hyperplasia in the Nipple-areolar Complex of Transmasculine Individuals”, published in Modern Pathology, has been selected as Best Clinical Paper 2023 by the BIDMC Cancer Research Institute.
Search
Search results
5232 results found
Understanding the variability of the electrophysiologic laryngeal adductor reflex.
Simon, Mirela, V, Seward B Rutkove, Long Ngo, Corey R Fehnel, Alvin S Das, Todd Sarge, Somnath Bose, Magdy Selim, and Sandeep Kumar. 2024. “Understanding the Variability of the Electrophysiologic Laryngeal Adductor Reflex.”. Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology 162: 141-50.
Targeting IL-1 controls refractory pityriasis rubra pilaris.
Schmauch, Eloi, Yannik Severin, Xianying Xing, Aaron Mangold, Curdin Conrad, Pål Johannsen, Michelle Kahlenberg, et al. 2024. “Targeting IL-1 Controls Refractory Pityriasis Rubra Pilaris.”. Science Advances 10 (27): eado2365.
The immunology of systemic lupus erythematosus.
Tsokos, George C. 2024. “The Immunology of Systemic Lupus Erythematosus.”. Nature Immunology 25 (8): 1332-43.
Reverse aging to treat lupus.
Pan, Wenliang, and George C Tsokos. 2024. “Reverse Aging to Treat Lupus.”. European Journal of Immunology, e2451274.
Introducing the New Cochrane Column for Global Advances in Integrative Medicine and Health.
Yeh, Gloria Y, Erik J Groessl, and Susan Wieland. 2024. “Introducing the New Cochrane Column for Global Advances in Integrative Medicine and Health.”. Global Advances in Integrative Medicine and Health 13: 27536130241261160.
Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.
Cheong, Jae Eun, and Lijun Sun. 2018. “Targeting the IDO1/TDO2-KYN-AhR Pathway for Cancer Immunotherapy - Challenges and Opportunities.”. Trends in Pharmacological Sciences 39 (3): 307-25.
A patent review of IDO1 inhibitors for cancer.
Cheong, Jae Eun, Anil Ekkati, and Lijun Sun. 2018. “A Patent Review of IDO1 Inhibitors for Cancer.”. Expert Opinion on Therapeutic Patents 28 (4): 317-30.
A PSGL-1 glycomimetic reduces thrombus burden without affecting hemostasis.
Wong, Daniel J, Diane D Park, Simon S Park, Carolyn A Haller, Jiaxuan Chen, Erbin Dai, Liying Liu, et al. 2021. “A PSGL-1 Glycomimetic Reduces Thrombus Burden Without Affecting Hemostasis.”. Blood 138 (13): 1182-93.
Eleifend quam adipiscing vitae proin sagittis nisl rhoncus mattis
Nisl pretium fusce id velit ut tortor pretium viverra suspendisse. Urna porttitor rhoncus dolor purus non enim praesent elementum. Felis donec et odio pellentesque diam volutpat commodo sed. Hic rerum possimus accusamus velit qui alias quia sit ipsa. Aspernatur qui dolores qui quod qui eos quas...